Interesting new publication suggesting that MPB should be assessed as a early warning sign for type-2 diabetes.
    12/22/2017

    New to Finasteride? There is a guide in the encyclopedia. Read the guide →
    At a glance
    In this educational post, the primary subjects mentioned are the tone is 😐 neutral.

    Other terms

    Male pattern baldness (MPB) may be an early warning sign for type 2 diabetes due to its association with insulin resistance. Treatments discussed include testosterone therapy and finasteride, which affects hormone levels related to hair loss and insulin sensitivity.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results

      research Alopecia and Thyroid Disease

      January 2008 in “Springer eBooks”
      Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

      research Dermatosis associated with menopause

      10 citations , January 2014 in “Journal of Mid-life Health”
      This article reviews dermatological problems associated with estrogen deficiency in menopausal women and highlights the importance of dermatologist and gynecologist collaboration, but reports no new clinical results.

      research Proceedings of the Ninth World Congress for Hair Research (2015)

      January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”
      This report discusses the Ninth World Congress for Hair Research and highlights the potential of hair follicle studies to advance understanding of various diseases, with no new clinical results presented.

      research Female pattern hair loss—An update

      12 citations , January 2020 in “Indian Dermatology Online Journal”
      This article discusses the causes, diagnosis, and treatment options for female pattern hair loss, emphasizing the role of topical minoxidil as a primary treatment, but provides no new clinical results.

      research A brief report on PCOS: and its inducing model

      January 2025 in “International Journal of Pharmaceutical Research and Applications”
      This review discusses the use of experimental animal models to better understand the poorly understood mechanisms behind polycystic ovarian syndrome and reports no new clinical results.